Reforming the 340B Discount Drug Program


McDermott healthcare lawyers were cited for their analysis of proposed Centers for Medicare and Medicaid Services cuts to the 340B Drug Discount Program. The McDermott analysis called the cuts “necessary to slow growth in the 340B program, shift trends of growing amounts paid by Medicare for outpatient hospital drugs and reduce Medicare beneficiary cost-sharing.”